Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Ipca Laboratories Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201103-06-2015
03-06-2015
Financial Results & Auditors Report for March 31, 2015 (Standalone) (Audited)
Mangalam Drugs & Organics Ltd has informed BSE about the Standalone Financial Results & a copy of the Auditors Report for the period ended March 31, 2015.15-05-2015
Change in Directorate
Mangalam Drugs & Organics Ltd has informed BSE about the following:1. That Mrs. Meenal Sukhani, who was earlier appointed on October 21, 2014 as an Additional Director - Non Executive on the Board of the Company is now appointed as an Independent director by the Board of directors on May 02, 2015. Thus effective May 02, 2015 Ms. Meenal Sukhani will be Additional Director - Independent....09-05-2015
Closure of Trading Window
Mangalam Drugs & Organics Ltd has informed BSE that the next meeting of the Board of Directors of the Company will be held on May 15, 2015, to consider annual audited financial results for the year ended on March 31, 2015.Further, in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992, the trading window...08-05-2015
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Ipca Laboratories Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201123-04-2015
Shareholding Pattern For March 31, 2015
Mangalam Drugs & Organics Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.22-04-2015
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Ipca Laboratories Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201109-04-2015
Clarification
With reference to the Increase in price, Mangalam Drugs & Organics Ltd has Clarified to BSE as under:"The Company has no pending announcements to make having a bearing on operation/performance of the Company or which may result in unusual price/volume behavior of the stock price."19-03-2015
Clarification sought from Mangalam Drugs & Organics Ltd
The Exchange has sought clarification from Mangalam Drugs & Organics Ltd with reference to increase in price on March 19, 2015. The reply is awaited.19-03-2015